phosphoserine and bromodeoxyuridine

phosphoserine has been researched along with bromodeoxyuridine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carmignac, D; Christie, MR; Foot, VL; Hauge-Evans, AC; Richardson, CC; To, K	1
Hamaoka, Y; Katoh, H; Negishi, M	1

Other Studies

2 other study(ies) available for phosphoserine and bromodeoxyuridine

Article	Year
Increased perinatal remodelling of the pancreas in somatostatin-deficient mice: potential role of transforming growth factor-beta signalling in regulating beta cell growth in early life. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2015, Volume: 47, Issue:1 Topics: Animals; Animals, Newborn; Apoptosis; Body Weight; Bromodeoxyuridine; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Female; In Situ Nick-End Labeling; Insulin-Secreting Cells; Male; Mice; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad Proteins; Somatostatin; Transforming Growth Factor beta	2015
EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation. Cellular signalling, 2016, Volume: 28, Issue:8 Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Glioblastoma; Humans; MAP Kinase Signaling System; Phosphorylation; Phosphoserine; Receptor, EphA2; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction	2016

Article

Year

Increased perinatal remodelling of the pancreas in somatostatin-deficient mice: potential role of transforming growth factor-beta signalling in regulating beta cell growth in early life.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2015, Volume: 47, Issue:1

Topics: Animals; Animals, Newborn; Apoptosis; Body Weight; Bromodeoxyuridine; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Female; In Situ Nick-End Labeling; Insulin-Secreting Cells; Male; Mice; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad Proteins; Somatostatin; Transforming Growth Factor beta

2015

EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation.

Cellular signalling, 2016, Volume: 28, Issue:8

Topics: Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; Glioblastoma; Humans; MAP Kinase Signaling System; Phosphorylation; Phosphoserine; Receptor, EphA2; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction

2016